For research use only. Not for therapeutic Use.
CYP1B1-IN-4 is a 2,4-diarylthiazole compound with selectively CYP1B1 inhibition (IC50=0.2 nM). CYP1B1-IN-4 has little cytotoxicity and high stability in both human and rat liver microsomes[1].
CYP1B1-IN-4 (compound 15) (100 μM; 37 ℃; 0-60 min) has in vitro stability in both human and rat liver microsomes, while it has low stability in mouse liver microsomes[1].
CYP1B1-IN-4 (1 nM-10 μM) also inhibits CYP1A1 with an IC50 value of 3.82 μM[1].
CYP1B1-IN-4 (200 μM; 72 h) parental HEK T-REx cell line , and (100 μ M; 72 h) has little cytotoxicity in HEK293 cells[1].
Stability Parameters in Human, Rat, or Mouse Liver Microsomes[1]
Parameters
T1/2 (min)
CLint(mic) (μL/min/mg)
CLint(liver) (mL/min/kg)
% remainingT=60 min
Human
28.3
49.0
44.1
19.0
Rat
36.6
37.9
68.2
27.1
Mouse
2.5
545.9
2161.9
0.2
Catalog Number | I042285 |
CAS Number | 2685779-55-7 |
Synonyms | 4-[2-(2,4-dimethoxyphenyl)-1,3-thiazol-4-yl]benzonitrile |
Molecular Formula | C18H14N2O2S |
Purity | ≥95% |
InChI | InChI=1S/C18H14N2O2S/c1-21-14-7-8-15(17(9-14)22-2)18-20-16(11-23-18)13-5-3-12(10-19)4-6-13/h3-9,11H,1-2H3 |
InChIKey | SCCIDJLIDOUTOW-UHFFFAOYSA-N |
SMILES | COC1=CC(=C(C=C1)C2=NC(=CS2)C3=CC=C(C=C3)C#N)OC |
Reference | [1]. Hachey AC, et al. Design of Cytochrome P450 1B1 Inhibitors via a Scaffold-Hopping Approach. J Med Chem. 2022 Dec 15. |